Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cardiovascular Diabetology is Scopus-indexed (Q1, CiteScore 18.7), WoS SCIE, DOAJ. It is covered by India's One Nation One Subscription scheme, which pays the article processing charge for authors at eligible institutions. Published by BioMed Central Ltd.
Checked against the index lists dated .
ISSN 1475-2840Verify ISSN ↗
Publisher: BioMed Central Ltd
Cost to publish: APC covered for authors at ONOS-subscribed Indian institutions
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Cardiology and Cardiovascular Medicine | 11 / 409 | 97th | Q1 |
| Internal Medicine | 7 / 179 | 96th | Q1 |
| Endocrinology, Diabetes and Metabolism | 13 / 250 | 95th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription)
Yes — actively indexed in Scopus, coverage 2002–present, best quartile Q1, CiteScore 18.7.
Cardiovascular Diabetology is Q1 in Cardiology and Cardiovascular Medicine (rank 11 of 409), Q1 in Internal Medicine (rank 7 of 179) and Q1 in Endocrinology, Diabetes and Metabolism (rank 13 of 250), by CiteScore 2025.
Cardiovascular Diabetology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 18.7, which places it in quartile Q1 at the 97th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 4.447, quartile Q1, with an H-index of 135.
For authors at Indian institutions covered by One Nation One Subscription (ONOS), the article processing charge is paid by the scheme. The publisher lists an article processing charge of about US$4,290 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Cardiovascular Diabetology is published by BioMed Central Ltd. Its ISSN is 1475-2840.
Yes. ONOS also covers its article processing charge for authors at eligible institutions.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Cardiovascular Diabetology has an h-index of 170 and a 2-year mean of 17.11 citations per paper (OpenAlex). Its Scopus CiteScore is 18.7, quartile Q1. On 2-year citations it ranks #2 of 398 Scopus journals in Cardiology and Cardiovascular Medicine.
Cardiovascular Diabetology published 495 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from China (41.7%), United States (6.7%) and Spain (4.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 6 retracted papers are recorded (1.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.